Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results ...
( OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects ...
This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...
During a live event, Hagen Kennecke, MD, discusses how RADIANT-4 and NETTER trials have reshaped NET care with everolimus and PRRT.
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...
-Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC”) Study in Treatment Resistant Depression ("TRD”) in ...
PITTSBURGH, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the fourth quarter and full year ending December 31, 2025 and ...
RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced that the independent Data ...
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
Real-time strategy games are usually about conquest. You expand your influence through various means to ultimately crush your opposition, as your economy and military scale out of control. The genre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results